Skip to main content
Top
Published in: Archives of Virology 5/2012

01-05-2012 | Original Article

Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China

Authors: Wei-Ling Wang, Zhi-Jun Shu, Li-Xia Zhou, Yan-Rong Zhao

Published in: Archives of Virology | Issue 5/2012

Login to get access

Abstract

The aim of this study was to investigate the prevalence of hepatitis B surface antigen (HBsAg) and clinical characteristics of middle school students infected with hepatitis B virus (HBV) after initiation of the HBV immunization program in China. A total of 82,156 serum samples were collected from students in 33 junior schools and 25 senior schools. HBsAg was tested by ELISA. Samples from HBsAg-positive students were collected and analyzed for HBV serum markers, alanine aminotransferase (ALT), HBV DNA levels, and HBV genotypes. The overall prevalence of HBsAg was 1.11% in middle school students in Shanghai, China. The prevalence of HBsAg in students born during the immunization program to HBsAg-positive mothers was significantly higher than that in students born during the universal vaccination program (1.47% vs 0.78%, P < 0.01). Only HBV genotypes B and C were found in these infections, and genotype C was the dominant one. Twenty-one (13.0%) of 162 HBsAg-positive students had active hepatitis B, and 18 were hepatitis B e antigen (HBeAg) positive. The universal infant vaccination program has reduced the prevalence of HBsAg significantly. HBeAg-positive hepatitis B, however, needs to be monitored among the students in whom vaccination failed.
Literature
1.
go back to reference Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC (2007) Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J 120:1155–1158PubMed Chen CC, Yen CH, Wu WY, Hu SW, Chen SC, Bell WR, Lee MC (2007) Epidemiology of hepatitis B virus infection among young adults in Taiwan, China after public vaccination program. Chin Med J 120:1155–1158PubMed
2.
go back to reference Chen DS, Sung JL, Lai MY (1978) A seroepidemiologic study of hepatitis B virus infection in Taiwan. J Formosan Med Assoc 77:908–918 Chen DS, Sung JL, Lai MY (1978) A seroepidemiologic study of hepatitis B virus infection in Taiwan. J Formosan Med Assoc 77:908–918
3.
go back to reference Cui FQ, Wang XJ, Cao L, Liang XF, Lu Y, Hu YS, Hadler SC, Shapiro CN, Wiersma ST, Ward JW (2007) Progress in hepatitis B prevention through universal infant vaccination—China, 1997–2006. MMWR 56:441–445 Cui FQ, Wang XJ, Cao L, Liang XF, Lu Y, Hu YS, Hadler SC, Shapiro CN, Wiersma ST, Ward JW (2007) Progress in hepatitis B prevention through universal infant vaccination—China, 1997–2006. MMWR 56:441–445
4.
go back to reference Ding X, Mizokami M, Yao G et al (2001) Hepatitis B virus genotypes distribution among chronic hepatitis B virus carriers in Shanghai. China Intervirol 44:43–47CrossRef Ding X, Mizokami M, Yao G et al (2001) Hepatitis B virus genotypes distribution among chronic hepatitis B virus carriers in Shanghai. China Intervirol 44:43–47CrossRef
5.
go back to reference Fang JW, Lai CL, Chung HT, Wu PC, Lau JY (1994) Female children respond to recombinant hepatitis B vaccine with a higher titer. J Trop Pediatr 40:104–107PubMed Fang JW, Lai CL, Chung HT, Wu PC, Lau JY (1994) Female children respond to recombinant hepatitis B vaccine with a higher titer. J Trop Pediatr 40:104–107PubMed
6.
go back to reference Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34:1329–1339PubMedCrossRef Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS (2005) A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34:1329–1339PubMedCrossRef
7.
go back to reference Huang MJ (1990) An epidemiological study on prevalence and risk factors of hepatitis B virus (HBV) infection in preschool children [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 11:129–132PubMed Huang MJ (1990) An epidemiological study on prevalence and risk factors of hepatitis B virus (HBV) infection in preschool children [Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 11:129–132PubMed
8.
go back to reference Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS (1999) Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 179:367–370PubMedCrossRef Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS (1999) Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 179:367–370PubMedCrossRef
9.
go back to reference Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study before mass hepatitis B vaccination program in Taiwan. J Med Virol 18:301–307PubMedCrossRef Hsu HY, Chang MH, Chen DS, Lee CY, Sung JL (1986) Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study before mass hepatitis B vaccination program in Taiwan. J Med Virol 18:301–307PubMedCrossRef
10.
go back to reference Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL (2003) Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 69:471–474PubMedCrossRef Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL (2003) Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 69:471–474PubMedCrossRef
12.
go back to reference Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y (2009) Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550–6557PubMedCrossRef
13.
go back to reference Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 2007(45):507–539CrossRef Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 2007(45):507–539CrossRef
14.
go back to reference Ministry of Health (2006) National plan for hepatitis B control and treatment in 2006 to 2010. Ministry of Health, Beijing, China (January 28) Ministry of Health (2006) National plan for hepatitis B control and treatment in 2006 to 2010. Ministry of Health, Beijing, China (January 28)
15.
go back to reference Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS (2001) Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796–800PubMed Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, Tsai KS, Chen DS (2001) Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 135:796–800PubMed
16.
go back to reference Poland GA, Jacobson RM (2004) Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351:2832–2838PubMedCrossRef Poland GA, Jacobson RM (2004) Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351:2832–2838PubMedCrossRef
17.
go back to reference Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, Jacquet JM (2011) Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 18:369–375PubMedCrossRef Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, Jacquet JM (2011) Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 18:369–375PubMedCrossRef
18.
go back to reference Xia GL, Liu CB, Cao HL (1996) Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 5:62–73CrossRef Xia GL, Liu CB, Cao HL (1996) Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun 5:62–73CrossRef
Metadata
Title
Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China
Authors
Wei-Ling Wang
Zhi-Jun Shu
Li-Xia Zhou
Yan-Rong Zhao
Publication date
01-05-2012
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2012
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-012-1251-9

Other articles of this Issue 5/2012

Archives of Virology 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.